澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

RHYTHM BIOSCIENCES LTD

0.073

-0.003-3.95%

成交量：12.69万

成交额：9,265

市值：2,583.23万

市盈率：-4.12

高：0.073

开：0.073

低：0.073

收：0.076

52周最高：0.280

52周最低：0.071

股本：3.54亿

流通股本：1.88亿

量比：24.17

换手率：0.07%

股息：- -

股息率：- -

每股收益(TTM):-0.018

每股收益(LYR):-0.018

净资产收益率：-276.00%

总资产收益率：-96.19%

市净率：7.10

市盈率(LYR):-4.12

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Rhythm Biosciences宣布：Gavin Fox-Smith即刻辞任董事长及非执行董事

Rhythm Biosciences宣布任命两位非执行董事，8月27日正式生效

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/RHY.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.073,"timestamp":1791846518907,"preClose":0.076,"halted":0,"volume":126920,"delay":0,"changeRate":-0.039473684210526355,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":353866857,"eps":-0.0177,"marketStatus":"交易中","change":-0.003,"latestTime":"10-13 10:08:57 AEDT","open":0.073,"high":0.073,"low":0.073,"amount":9265,"amplitude":0,"askPrice":0.075,"askSize":8738,"bidPrice":0.073,"bidSize":2347,"shortable":3,"etf":0,"ttmEps":-0.0177,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791867600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.076,"openAndCloseTimeList":[[1791846000000,1791867600000]],"volumeRatio":24.172568,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RHY.AU","preClose":0.072,"auctionPrice":0.072,"auctionVolume":7684,"auction":3,"marketStatus":"盘后竞价","timestamp":1791522279311}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-96.19%","roe":"-276.00%","lyrEps":-0.0177,"volumeRatio":24.172568,"shares":353866857,"dividePrice":0,"high":0.073,"amplitude":0,"preClose":0.076,"low":0.073,"week52Low":0.071,"pbRate":"7.10","psRate":"14.84","week52High":0.28,"institutionHeld":0,"latestPrice":0.073,"committee":-0.576545,"eps":-0.0177,"divideRate":0,"volume":126920,"delay":0,"ttmEps":-0.0177,"open":0.073,"prevYearClose":0.135,"prevWeekClose":0.075,"prevMonthClose":0.081,"prevQuarterClose":0.081,"fiveDayClose":0.078,"twentyDayClose":0.08,"sixtyDayClose":0.085,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1170493031","title":"Rhythm Biosciences宣布：Gavin Fox-Smith即刻辞任董事长及非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1170493031","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170493031?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 06:12","pubTimestamp":1790633550,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences Ltd（RHY.AU）发布消息称，Gavin Fox-Smith已辞去公司董事长及非执行董事职务，辞任即刻生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178839475","title":"Rhythm Biosciences宣布任命两位非执行董事，8月27日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1178839475","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178839475?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 06:08","pubTimestamp":1787695689,"startTime":"0","endTime":"0","summary":"生物科技公司Rhythm Biosciences（RHY.AU）今日发布公告，宣布任命Maureen Baker和Carl Stubbings为非执行董事。据悉，该项人事任命将于2026年8月27日正式生效。\n这一董事会层面的新变动，标志着公司在治理结构上的进一步调整与优化。两位新任董事的加入，料将为公司带来更为多元化的经验与视角。\n作为一家专注于生物科技领域的企业，Rhythm Biosciences此次人事布局，或为其未来发展战略注入新的活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RHY.AU\",params:#limit:6,delay:true,,,undefined,":[]}}